If you made any changes in Pure, your changes will be visible here soon.

Research Output 1989 2019

Filter
Short survey
2009

Use of 5-α-reductase inhibitors for prostate cancer chemoprevention: American society of clinical oncology/American Urological Association 2008 clinical practice guideline summary

Kramer, B. S., Hagerty, K. L., Justman, S., Somerfield, M. R., Albertsen, P. C., Blot, W. J., Carter, H. B., Costantino, J. P., Epstein, J. I., Godley, P., Harris, R. P., Wilt, T. J., Wittes, J., Zon, R. & Schellhammer, P., May 1 2009, In : Journal of Oncology Practice. 5, 3, p. 127-129 3 p.

Research output: Contribution to journalShort survey

5-alpha Reductase Inhibitors
Medical Oncology
Chemoprevention
Practice Guidelines
Prostatic Neoplasms
2003

Review: Terazosin improves urological symptoms in benign prostatic hyperplasia

Wilt, T. J., Howe, R. W. & Rutks, I. R., May 1 2003, In : Evidence-Based Medicine. 8, 3, 1 p.

Research output: Contribution to journalShort survey

Terazosin
Prostatic Hyperplasia